Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1963 3
1964 3
1965 3
1966 2
1967 1
1968 3
1969 5
1970 4
1971 3
1972 2
1973 1
1974 2
1976 5
1977 1
1978 1
1979 1
1980 2
1981 5
1982 2
1983 1
1984 1
1985 1
1986 3
1987 2
1988 3
1989 5
1990 8
1991 4
1992 6
1993 8
1994 6
1995 3
1996 3
1997 3
1998 2
1999 1
2000 7
2001 4
2002 6
2003 9
2004 5
2005 4
2006 4
2007 4
2008 4
2009 5
2010 6
2011 4
2012 6
2013 4
2014 9
2015 18
2016 21
2017 14
2018 16
2019 13
2020 51
2021 63
2022 77
2023 78
2024 79
2025 56

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

616 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Patil VM, et al. Among authors: menon n. J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015. Epub 2022 Oct 20. J Clin Oncol. 2023. PMID: 36265101 Clinical Trial.
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: menon n. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.
Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K. Noronha V, et al. Among authors: menon n. J Clin Oncol. 2020 Jan 10;38(2):124-136. doi: 10.1200/JCO.19.01154. Epub 2019 Aug 14. J Clin Oncol. 2020. PMID: 31411950 Clinical Trial.
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.
Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I. Ostwal V, et al. Among authors: menon n. JAMA Netw Open. 2024 Aug 1;7(8):e2426076. doi: 10.1001/jamanetworkopen.2024.26076. JAMA Netw Open. 2024. PMID: 39106066 Free PMC article. Clinical Trial.
Use of Low-Titer O-Positive Whole Blood in Female Trauma Patients: A Literature Review, Qualitative Multidisciplinary Analysis of Risk/Benefit, and Guidelines for Its Use as a Universal Product in Hemorrhagic Shock.
Clements TW, Van Gent JM, Menon N, Roberts A, Sherwood M, Osborn L, Hartwell B, Refuerzo J, Bai Y, Cotton BA. Clements TW, et al. Among authors: menon n. J Am Coll Surg. 2024 Mar 1;238(3):347-357. doi: 10.1097/XCS.0000000000000906. Epub 2023 Nov 6. J Am Coll Surg. 2024. PMID: 37930900 Review.
Immunotherapy related colitis.
Wagh VA, Sundaram S, Menon NN, Deodhar KK. Wagh VA, et al. Among authors: menon nn. Indian J Pathol Microbiol. 2021 Oct-Dec;64(4):857-859. doi: 10.4103/ijpm.ijpm_477_21. Indian J Pathol Microbiol. 2021. PMID: 34673627 No abstract available.
Point-of-care diagnostic tests for tuberculosis disease.
Hong JM, Lee H, Menon NV, Lim CT, Lee LP, Ong CWM. Hong JM, et al. Among authors: menon nv. Sci Transl Med. 2022 Apr 6;14(639):eabj4124. doi: 10.1126/scitranslmed.abj4124. Epub 2022 Apr 6. Sci Transl Med. 2022. PMID: 35385338 Review.
Occult maculopathy.
Menon N, Jampol LM. Menon N, et al. Retin Cases Brief Rep. 2012 Winter;6(1):33-6. doi: 10.1097/ICB.0b013e3181fe92d1. Retin Cases Brief Rep. 2012. PMID: 25390706
Improving Wellbeing After Acute Coronary Syndrome.
Liblik K, Théberge E, Gomes Z, Burbidge E, Menon N, Gobran J, Johri AM. Liblik K, et al. Among authors: menon n. Curr Probl Cardiol. 2023 Aug;48(8):101201. doi: 10.1016/j.cpcardiol.2022.101201. Epub 2022 Apr 7. Curr Probl Cardiol. 2023. PMID: 35398360 Review.
616 results